Arkis BioSciences develops advanced treatments for intracranial hypertension, including hydrocephalus and other related disorders, ranging from surgical tools to state of the art implantables. Founded in 2011 by a neurosurgeon, former engineering patent examiner, and business developer, Arkis began development of a portfolio of products that results in safer and less invasive surgeries as well as improved shunt options to result in personalized treatments for a leap in patient outcomes.
View Top Employees from Arkis BioSciencesWebsite | http://www.arkisbiosciences.com |
Revenue | $3 million |
Funding | $3.4 million |
Employees | 10 (1 on RocketReach) |
Founded | 2011 |
Address | 1 Momentum Way, Knoxville, Tennessee 37920, US |
Phone | (844) 247-5383 |
Technologies |
JavaScript,
HTML,
Microsoft Outlook
+3 more
(view full list)
|
Industry | Biotechnology, Medical Devices & Equipment, Manufacturing, Science and Engineering, Health Care, Medical Device |
Web Rank | 32 Million |
Keywords | Medtech External Ventricular Drain |
Competitors | MedShift, Mespere LifeSciences, NeoChord, Inc., SOLOS ENDOSCOPY, INC., VGI Medical, LLC |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
Looking for a particular Arkis BioSciences employee's phone or email?
The Arkis BioSciences annual revenue was $3 million in 2023.
James Killeffer is the Chief Medical Officer of Arkis BioSciences.
1 people are employed at Arkis BioSciences.
Arkis BioSciences is based in Knoxville, Tennessee.
The SIC codes for Arkis BioSciences are [38, 384].